NASDAQ:XTLB

Xtl Biopharmaceuticals Stock Forecast

etoro logo Buy XTLB
*Your capital is at risk
$2.70
+0.160 (+6.30%)
At Close: Jun 22, 2026
AI Analysis AI Analysis of XTLB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add XTLB to Watchlist?
Some Reasons Why To Add XTLB:
  • Lower volatility than the market (beta 0.56)
  • Established player in the Healthcare sector
  • +12.6% YTD performance
PDF

Volatile ride for XTL Biopharmaceuticals Ltd. stock price on Monday moving between $2.36 and $2.82
(Updated on Jun 22, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Jun 22, 2026

The XTL Biopharmaceuticals Ltd. stock price gained 6.30% on the last trading day (Monday, 22nd Jun 2026), rising from $2.54 to $2.70. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 19.45% from a day low at $2.36 to a day high of $2.82. The price has risen in 8 of the last 10 days and is up by 31.07% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 16 thousand more shares were traded than the day before. In total, 26 thousand shares were bought and sold for approximately $71.26 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.40% during the next 3 months and, with a 90% probability hold a price between $1.94 and $3.63 at the end of this 3-month period.

XTLB Signals & Forecast

Mostly positive signals in the chart today. The XTL Biopharmaceuticals Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $2.40 and $2.59. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, June 05, 2026, and so far it has risen 31.07%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). XTL Biopharmaceuticals Ltd. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for XTL Biopharmaceuticals Ltd. stock

XTL Biopharmaceuticals Ltd. finds support from accumulated volume at $2.67 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.459 between high and low, or 19.45%. For the last week, the stock has had daily average volatility of 9.65%.

Our recommended stop-loss: $2.60 (-3.78%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 10 days ago.)

Trading Expectations (XTLB) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect XTL Biopharmaceuticals Ltd. to open at $2.63, and during the day (based on 14 day Average True Range), to move between $2.59 and $2.81, which gives a possible trading interval of +/-$0.227 (+/-8.77%) up or down from last closing price. If XTL Biopharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 8.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.71 (0.37%) than the support at $2.67 (1.11%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is XTL Biopharmaceuticals Ltd. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 4.166 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $2.63 ( 2.73%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

XTLB Performance

Trading levels for XTLB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.09 14.28%
R2 2.91 7.78%
R1 2.80 3.77%
Price 2.70
S1 2.45 -9.22%
S2 2.34 -13.24%
S3 2.17 -19.73%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.25 20.37%
R2 2.85 5.56%
R1 2.71 0.370%
Price 2.70
S1 2.67 -1.11%
S2 2.61 -3.33%
S3 2.38 -11.85%

FAQ

What is the symbol for XTL Biopharmaceuticals Ltd. Stock and on which exchange is it traded?
The symbol for XTL Biopharmaceuticals Ltd. is XTLB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell XTL Biopharmaceuticals Ltd. Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

How to buy XTL Biopharmaceuticals Ltd. Stock?
XTL Biopharmaceuticals Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy XTL Biopharmaceuticals Ltd. Stock.

What's the current price of XTL Biopharmaceuticals Ltd. Stock?
As of the end of day on the Jun 22, 2026, the price of an XTL Biopharmaceuticals Ltd. (XTLB) share was $2.70.

What is the 52-week high and low for XTL Biopharmaceuticals Ltd. Stock?
The 52-week high for XTL Biopharmaceuticals Ltd. Stock is $19.94 and the 52-week low is $2.02.

What is the market capitalization of XTL Biopharmaceuticals Ltd. Stock?
As of the Jun 22, 2026, the market capitalization of XTL Biopharmaceuticals Ltd. is 6.387M.
Click to get the best stock tips daily for free!
ABOUT XTL BIOPHARMACEUTICALS LTD.
XTL Biopharmaceuticals
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCD...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE